查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1964076

微生物菌群定序服务市场－全球产业规模、份额、趋势、机会、预测：按技术、应用、地区和竞争格局划分，2021-2031年

Microbiome Sequencing Service Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology, By Application, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球微生物定序服务市场预计将从 2025 年的 3.2612 亿美元成长到 2031 年的 4.4231 亿美元，复合年增长率为 5.21%。

这些服务透过对微生物群落进行基因组分析来表征微生物，并将其应用于各种工业和临床用途，其主要驱动力是先进定序技术成本的显着降低以及对依赖微生物数据的精准医疗日益增长的需求。为了支持推动这一需求的活跃研究活动，欧洲神经胃肠动力学会于2024年报告称，过去十年中与肠道微生物组相关的论文数量已达到53,450篇，凸显了商业性定序需求的强劲增长势头。

市场概览
预测期 2027-2031
市场规模：2025年 3.2612亿美元
市场规模：2031年 4.4231亿美元
复合年增长率：2026-2031年 5.21%
成长最快的细分市场 合成定序
最大的市场 北美洲

阻碍市场成长的主要障碍是实验流程和数据分析缺乏标准化通讯协定。 DNA提取和解读方法的不统一导致研究结果不一致，使得基于微生物组的诊断方法难以检验结果并获得监管部门核准。这些差异使科学格局复杂化，并阻碍了微生物定序服务广泛接受和应用所需的统一标准的建立。

市场驱动因素

高通量总体基因体学技术的进步正在从根本上改变全球市场，它提高了数据生成能力，并降低了准入门槛。超高通量定序平台的引入极大地加速了微生物DNA的处理，使得以往成本高昂的大规模群体研究在经济上变得可行。数据生产能力的激增正在推动服务业的成长，因为实验室正在升级基础设施，以提供高效的深度元基因组分析。例如，Illumina在其2025年6月发布的《2024年企业社会责任报告》中指出，该公司在2024年全年利用其平台每分钟测序10个人类基因组，这表明现代基因组分析的强大处理能力为服务提供商提供了以具有竞争力的价格提供更深入见解的基础。

第二个主要驱动力是基于微生物组的药物发现和治疗方法的扩展。这需要专门的定序来检验生物医学产品。随着製药公司从相关性研究转向基于因果关係的药物发现，对符合菌株安全性和鑑定监管标准的精准定序的需求日益增长。这一趋势得到了大量投资的支持，例如32 Biosciences在2025年6月成功完成600万美元的资金筹措，以加速其肠道微生物组平台的开发（根据《微生物组时报》报道）。此外，诸如MaaT Pharma和Clinigen在2025年7月达成的独家合作协议等策略合作，旨在简化微生物组疗法的市场进入，也凸显了该行业对高品质基因组数据的依赖。

市场挑战

实验室操作流程和数据分析缺乏标准化通讯协定，是全球微生物组定序服务市场发展的一大障碍。生物资讯流程和DNA萃取技术的差异常常导致数据输出不一致，使得不同机构和研究的结果难以比较。这种可重复性不足是监管机构检验的主要障碍，因为监管机构需要可靠且一致的数据才能核准新的诊断和治疗方法。因此，对数据品质的担忧正在阻碍投资，延缓微生物组研究成果向可上市临床产品的转化，并减少商业性定序合约的数量。

近期行业数据进一步凸显了数据效用方面的挑战。根据皮斯托亚联盟 (Pistoia Alliance) 2024 年的报告，48% 的生命科学专业人士认为元资料缺乏标准化是有效利用实验数据的主要障碍。这项统计数据表明，数据处理中的不一致仍然是一个普遍存在的问题，降低了定序结果的价值。除非这些标准化方面的差距得到弥合，否则市场将难以提供可靠且可操作的洞察，而这些洞察对于推动整个产业的广泛应用至关重要。

市场趋势

将人工智慧 (AI) 和机器学习 (ML) 结合进行复杂资料解读，正成为管理多维微生物资料集复杂性的关键趋势。随着元基因组资料量的激增，传统的生物资讯工具往往难以检测宿主表型与微生物分类群之间的非线性关係，促使业界采用先进的计算模型进行更深入的功能分析。这些人工智慧驱动的框架对于将原始基因组数据转化为临床可用的生物标记至关重要，从而提升定序服务的价值，使其超越简单的分类。为了顺应这一转变，DNAstack 于 2025 年 2 月宣布了一项 1,750 万美元的倡议，旨在扩展其软体，加速人工智慧驱动的基因组学和医疗保健领域的发现。这标誌着 DNAstack 向运算基础设施的策略性转型，以最大限度地发挥微生物组数据的潜力。

同时，面向消费者的直接微生物组检测和个人化营养的兴起，正将市场拓展到传统临床和学术领域之外。大众对肠道健康的日益关注，推动了定序的健康产品的商业化，供应商透过解读微生物谱，提供切实可行的饮食和生活方式建议。这一趋势正将收入来源转向大规模消费者样本，这需要与小规模调查计划截然不同的可扩展处理流程。为了支持这一成长，Microba Life Sciences 在 2025 年 8 月的中期报告中指出，其营收成长了 29.6%，达到 1,560 万美元。这一增长显然与公司旗舰检测产品的普及密切相关，证明了个人化微生物组洞察的商业性可行性。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球微生物定序服务市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 依技术（合成定定序、连接定定序、桑格法等）
    • 按应用领域（自体免疫疾病、癌症、消化系统疾病等）
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美微生物定序服务市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲微生物群定序服务市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区微生物定序服务市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲微生物群定序服务市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美微生物定序服务市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章：全球微生物定序服务市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Microbiome Insights
  • BaseClear BV
  • Clinical Microbiomics A/S
  • Merieux NutriSciences Corporation
  • MR DNA（Molecular Research LP）
  • Prescient Medicine Holdings, Inc.
  • Rancho Biosciences LLC
  • Second Genome Inc.
  • Zymo Research Corporation
  • uBiome, Inc.

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 24555

The Global Microbiome Sequencing Service Market is projected to expand from USD 326.12 Million in 2025 to USD 442.31 Million by 2031, registering a CAGR of 5.21%. These services involve the genomic analysis of microbial communities to characterize microorganisms for various industrial and clinical purposes, driven largely by significant cost reductions in advanced sequencing technologies and the increasing demand for precision medicine dependent on microbial data. Underscoring the intense research activity fueling this demand, the European Society of Neurogastroenterology and Motility reported in 2024 that the number of publications regarding the gut microbiome had reached 53,450 over the previous decade, highlighting the strong momentum behind commercial sequencing requirements.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 326.12 Million
Market Size 2031USD 442.31 Million
CAGR 2026-20315.21%
Fastest Growing SegmentSequencing by synthesis
Largest MarketNorth America

A primary obstacle hindering market growth is the lack of standardized protocols for laboratory procedures and data analysis. Inconsistent methods for DNA extraction and interpretation lead to discrepancies across studies, creating difficulties in validating results and obtaining regulatory approval for diagnostics derived from microbiome data. These variations complicate the scientific landscape, making it harder to establish unified benchmarks necessary for the broader acceptance and application of microbiome sequencing services.

Market Driver

Technological advancements in high-throughput metagenomics are fundamentally transforming the global market by boosting data generation capabilities and reducing barriers to entry. The deployment of ultra-high-throughput sequencing platforms has significantly accelerated the processing of microbial DNA, making large-scale population studies economically viable where they were once cost-prohibitive. This surge in data production capacity is driving growth in the service sector as laboratories update their infrastructure to provide deep metagenomic analysis efficiently. For instance, in its June 2025 '2024 Corporate Social Responsibility Report', Illumina noted that 10 human genomes were sequenced every minute on their platforms throughout 2024, demonstrating the massive scale of modern genomic throughput that enables providers to deliver deeper insights at competitive prices.

A second major catalyst is the expansion of microbiome-based drug discovery and therapeutics, which necessitates specialized sequencing to validate live biotherapeutic products. As pharmaceutical companies shift focus from correlative studies to causative drug development, the demand for precision sequencing to meet regulatory standards for strain safety and identification has intensified. This trend is supported by significant investment, such as the $6 million funding secured by 32 Biosciences in June 2025 to advance its gut microbiome platform, as reported by Microbiome Times. Furthermore, strategic collaborations like the July 2025 exclusive agreement between MaaT Pharma and Clinigen to streamline market access for microbiome therapies further confirm the industrial reliance on high-quality genomic data.

Market Challenge

The absence of standardized protocols for laboratory procedures and data analysis serves as a critical barrier to the Global Microbiome Sequencing Service Market. Differences in bioinformatics pipelines and DNA extraction techniques frequently result in inconsistent data outputs, creating challenges when comparing results across various institutions or studies. This lack of reproducibility imposes significant hurdles for regulatory validation, as agencies mandate robust and consistent data to approve new diagnostics and therapeutics. Consequently, concerns regarding data quality discourage investment and delay the transformation of microbiome research into marketable clinical products, thereby dampening the volume of commercial sequencing contracts.

This challenge is further illustrated by recent industry data concerning data utility. In 2024, the Pistoia Alliance reported that 48% of life science professionals cited the lack of metadata standardization as a primary obstacle to effectively utilizing experimental data. This statistic underscores that inconsistencies in data handling remain a widespread issue that diminishes the value of sequencing results. As long as these standardization gaps persist, the market will struggle to provide the reliable, actionable insights required to foster widespread industrial adoption.

Market Trends

The integration of Artificial Intelligence and Machine Learning for complex data interpretation is becoming a key trend to manage the intricacies of multi-dimensional microbial datasets. As the volume of metagenomic data increases, traditional bioinformatics tools often fail to detect non-linear relationships between host phenotypes and microbial taxa, driving the industry to adopt advanced computational models for deeper functional analysis. These AI-driven frameworks are crucial for translating raw genomic data into clinically useful biomarkers, enhancing the value of sequencing services beyond basic classification. Reflecting this shift, DNAstack announced a $17.5 million initiative in February 2025 to expand software for AI-powered discoveries in genomics and healthcare, highlighting the sector's strategic move toward computational infrastructure to maximize the potential of microbiome data.

Concurrently, the rise of Direct-to-Consumer microbiome testing and personalized nutrition is extending the market's reach beyond traditional clinical and academic spheres. Growing public interest in gut health is fueling the commercialization of sequencing-based wellness products, where providers interpret microbial profiles to offer actionable dietary and lifestyle advice. This trend shifts revenue streams toward high-volume consumer samples, requiring scalable processing pipelines distinct from low-volume research projects. Evidencing this growth, Microba Life Sciences reported a 29.6% revenue increase to $15.6 million in their August 2025 preliminary report, a rise explicitly linked to the growing adoption of their core testing products, validating the commercial viability of personalized microbiome insights.

Key Market Players

  • Microbiome Insights
  • BaseClear BV
  • Clinical Microbiomics A/S
  • Merieux NutriSciences Corporation
  • MR DNA (Molecular Research LP)
  • Prescient Medicine Holdings, Inc.
  • Rancho Biosciences LLC
  • Second Genome Inc.
  • Zymo Research Corporation
  • uBiome, Inc.

Report Scope

In this report, the Global Microbiome Sequencing Service Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Microbiome Sequencing Service Market, By Technology

  • Sequencing by synthesis
  • Sequencing by ligation
  • Sanger sequencing
  • Others

Microbiome Sequencing Service Market, By Application

  • Autoimmune Disorder
  • Cancer
  • Gastrointestinal Disorders
  • Others

Microbiome Sequencing Service Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Microbiome Sequencing Service Market.

Available Customizations:

Global Microbiome Sequencing Service Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Microbiome Sequencing Service Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Technology (Sequencing by synthesis, Sequencing by ligation, Sanger sequencing, Others)
    • 5.2.2. By Application (Autoimmune Disorder, Cancer, Gastrointestinal Disorders, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Microbiome Sequencing Service Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Technology
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Microbiome Sequencing Service Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Technology
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Microbiome Sequencing Service Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Technology
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Microbiome Sequencing Service Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Technology
        • 6.3.3.2.2. By Application

7. Europe Microbiome Sequencing Service Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technology
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Microbiome Sequencing Service Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Technology
        • 7.3.1.2.2. By Application
    • 7.3.2. France Microbiome Sequencing Service Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Technology
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Microbiome Sequencing Service Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Technology
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Microbiome Sequencing Service Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Technology
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Microbiome Sequencing Service Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Technology
        • 7.3.5.2.2. By Application

8. Asia Pacific Microbiome Sequencing Service Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technology
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Microbiome Sequencing Service Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Technology
        • 8.3.1.2.2. By Application
    • 8.3.2. India Microbiome Sequencing Service Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Technology
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Microbiome Sequencing Service Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Technology
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Microbiome Sequencing Service Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Technology
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Microbiome Sequencing Service Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Technology
        • 8.3.5.2.2. By Application

9. Middle East & Africa Microbiome Sequencing Service Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technology
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Microbiome Sequencing Service Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Technology
        • 9.3.1.2.2. By Application
    • 9.3.2. UAE Microbiome Sequencing Service Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Technology
        • 9.3.2.2.2. By Application
    • 9.3.3. South Africa Microbiome Sequencing Service Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Technology
        • 9.3.3.2.2. By Application

10. South America Microbiome Sequencing Service Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Technology
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Microbiome Sequencing Service Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Technology
        • 10.3.1.2.2. By Application
    • 10.3.2. Colombia Microbiome Sequencing Service Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Technology
        • 10.3.2.2.2. By Application
    • 10.3.3. Argentina Microbiome Sequencing Service Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Technology
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Microbiome Sequencing Service Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Microbiome Insights
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. BaseClear BV
  • 15.3. Clinical Microbiomics A/S
  • 15.4. Merieux NutriSciences Corporation
  • 15.5. MR DNA (Molecular Research LP)
  • 15.6. Prescient Medicine Holdings, Inc.
  • 15.7. Rancho Biosciences LLC
  • 15.8. Second Genome Inc.
  • 15.9. Zymo Research Corporation
  • 15.10. uBiome, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer